| 1. |
Hunt RH, Xiao SD, Megraud F, et al. World gastroenterology organisation global guideline: Helicobacter pylori in developing countries. J Dig Dis, 2011, 12(5): 319-326.
|
| 2. |
Zhuge L, Wang Y, Wu S, et al. Furazolidone treatment for Helicobacter Pylori infection: a systematic review and meta-analysis. Helicobacter, 2018, 23(2): e12468.
|
| 3. |
Chen L, He J, Wang L, et al. Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial. Clin Exp Med, 2018, 18(4): 569-576.
|
| 4. |
弋東敏, 周炳喜, 丁松澤, 等. 含呋喃唑酮四聯方案初次根除幽門螺桿菌的療效及效價比評估. 胃腸病學和肝病學雜志, 2017, 26(6): 673-677.
|
| 5. |
Mazza JJ, Kryda MD. Tetracycline-induced hemolytic anemia. J Am Acad Dermatol, 1980, 2(6): 506-508.
|
| 6. |
Simpson MB, Pryzbylik J, Innis B, et al. Hemolytic anemia after tetracycline therapy. N Engl J Med, 1985, 312(13): 840-842.
|
| 7. |
李燕梅. 神經元特異性烯醇化酶評估中毒性腦病腦損傷的價值. 中華實用診斷與治療雜志, 2014, 28(9): 893-894.
|
| 8. |
Risso FM, Serpero LD, Zimmermann LJ, et al. Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr, 2013, 102(10): e467-e472.
|
| 9. |
邱建武, 刁詩光, 劉曉燕, 等. 新生兒膽紅素腦病監測 NSE 的意義. 中國婦幼健康研究, 2016, 27(12): 1445-1446.
|
| 10. |
陳清, 錢霜霜, 林鋒. NSE 聯合 NPY 對新生兒高膽紅素血癥腦損傷早期診斷的臨床意義. 重慶醫學, 2019, 48(10): 1784-1786.
|
